Search Results - "Wei Jing Loo"
-
1
Psoriasis and Multiple Sclerosis: Is There a Link?
Published in Journal of Cutaneous Medicine and Surgery (01-07-2010)“…Background: Psoriasis and multiple sclerosis (MS) are both autoimmune T cell-mediated diseases. Some case series have suggested an association. Objective: To…”
Get full text
Book Review Journal Article -
2
Management of autoimmune skin disorders in the elderly
Published in Drugs & aging (01-01-2004)“…Senescence of the skin immunological system may explain why the elderly population has an increased susceptibility to certain autoimmune skin disorders. These…”
Get full text
Journal Article -
3
Inhibition of Receptor-Interacting Protein Kinase 1 in Chronic Plaque Psoriasis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
Published in Dermatology and therapy (01-02-2024)“…Introduction Receptor-interacting protein kinase 1 (RIPK1), a key mediator of inflammation through necroptosis and proinflammatory cytokine production, may…”
Get full text
Journal Article -
4
The Coexistence of Psoriasis and Vitiligo: A review
Published in Journal of Cutaneous Medicine and Surgery (01-09-2012)“…Background: Psoriasis and vitiligo are both autoimmune diseases with an increased incidence noted in genetic relatives. They share similar trigger factors and…”
Get full text
Book Review Journal Article -
5
354 Genital involvement in patients with atopic dermatitis is associated with sexual difficulties and higher disease burden: results from a real-world multicountry cohort study (MEASURE-AD)
Published in British journal of dermatology (1951) (25-01-2023)“…Abstract Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease characterized by erythematous and pruritic lesions. Genital involvement of AD…”
Get full text
Journal Article -
6
-
7
-
8
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
Published in EClinicalMedicine (01-03-2023)“…Prurigo nodularis is a chronic skin disease characterised by intensely pruritic, hyperkeratotic nodules. Vixarelimab, a human monoclonal antibody, binds to the…”
Get full text
Journal Article -
9
Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial
Published in Journal of the American Academy of Dermatology (01-08-2024)“…Efficacy and/or safety profiles limit topical psoriasis treatments. Evaluate long-term effects of once-daily roflumilast cream 0.3% in patients with psoriasis…”
Get full text
Journal Article -
10
Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway
Published in Journal of cutaneous medicine and surgery (01-01-2023)“…Cytokines in the interleukin (IL)−23/IL-17 axis are central to psoriasis pathogenesis. Janus kinase (JAK) signal transducer and activator of transcription…”
Get full text
Journal Article -
11
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyResearch in context
Published in EClinicalMedicine (01-03-2023)“…Background: Prurigo nodularis is a chronic skin disease characterised by intensely pruritic, hyperkeratotic nodules. Vixarelimab, a human monoclonal antibody,…”
Get full text
Journal Article -
12
Case 2
Published in Clinical and experimental dermatology (01-09-2003)Get full text
Journal Article -
13
Clinical management where medicine meets management. More than skin deep
Published in The Health service journal (21-10-2004)“…Modernisation has brought down outpatient waits and did-not-attends at Addenbrooke Hospital's dermatology department. A 360-degree review of services has led…”
Get more information
Journal Article